Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
71.44
-0.83 (-1.15%)
At close: Oct 24, 2025, 4:00 PM EDT
71.98
+0.54 (0.76%)
After-hours: Oct 24, 2025, 7:01 PM EDT
Solventum Revenue
Solventum had revenue of $2.16B in the quarter ending June 30, 2025, with 3.84% growth. This brings the company's revenue in the last twelve months to $8.39B, up 2.21% year-over-year. In the year 2024, Solventum had annual revenue of $8.25B with 0.70% growth.
Revenue (ttm)
$8.39B
Revenue Growth
+2.21%
P/S Ratio
1.48
Revenue / Employee
$381,273
Employees
22,000
Market Cap
12.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.25B | 57.00M | 0.70% |
| Dec 31, 2023 | 8.20B | 67.00M | 0.82% |
| Dec 31, 2022 | 8.13B | -41.00M | -0.50% |
| Dec 31, 2021 | 8.17B | 890.00M | 12.22% |
| Dec 31, 2020 | 7.28B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SOLV News
- 2 days ago - Solventum: A Solid Performance Here - Seeking Alpha
- 3 days ago - Solventum Appoints Heather Knight as Chief Commercial Officer - PRNewsWire
- 8 days ago - Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025 - PRNewsWire
- 6 weeks ago - Solventum Corporation (SOLV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers - PRNewsWire
- 6 weeks ago - Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers - PRNewsWire
- 7 weeks ago - Solventum Corporation (SOLV) Presents At 2025 Wells Fargo Healthcare Conference (Transcript) - Seeking Alpha
- 7 weeks ago - Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. - PRNewsWire